Page last updated: 2024-10-21

pk 11195 and REM Sleep Behavior Disorder

pk 11195 has been researched along with REM Sleep Behavior Disorder in 1 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

REM Sleep Behavior Disorder: A disorder characterized by episodes of vigorous and often violent motor activity during REM sleep (SLEEP, REM). The affected individual may inflict self injury or harm others, and is difficult to awaken from this condition. Episodes are usually followed by a vivid recollection of a dream that is consistent with the aggressive behavior. This condition primarily affects adult males. (From Adams et al., Principles of Neurology, 6th ed, p393)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Stær, K1
Iranzo, A1
Stokholm, MG1
Østergaard, K1
Serradell, M1
Otto, M1
Svendsen, KB1
Garrido, A1
Vilas, D1
Santamaria, J1
Møller, A1
Gaig, C1
Brooks, DJ1
Borghammer, P1
Tolosa, E1
Pavese, N1

Other Studies

1 other study available for pk 11195 and REM Sleep Behavior Disorder

ArticleYear
Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder.
    Parkinsonism & related disorders, 2020, Volume: 81

    Topics: Acetylcholinesterase; Aged; Carbon Radioisotopes; Cerebral Cortex; Cholinesterase Inhibitors; Cognit

2020